ストックスクリーナーアプリを入手
4.06
6.67%
-0.29
アフターアワーズ：
4.05
-0.010
-0.25%
前日終値:
$4.35
開ける：
$4.35
24時間の取引高:
35,551
Relative Volume:
0.52
時価総額：
$54.57M
収益：
$1.93M
当期純損益:
$-7.96M
株価収益率:
-0.00115
EPS:
-3530.8178
ネットキャッシュフロー:
$-36.78M
1週間 パフォーマンス:
-19.44%
1か月 パフォーマンス:
-20.39%
6か月 パフォーマンス:
-69.50%
1年 パフォーマンス:
-64.66%
1日の値動き範囲:
$4.06
$4.40
1週間の範囲:
$4.06
$5.2625
52週間の値動き範囲:
$4.06
$16.00
Avalo Therapeutics Inc Stock (AVTX) Company Profile
AVTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
4.06 | 54.57M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-25 | 開始されました | Jefferies | Buy |
| 2025-03-25 | 開始されました | Stifel | Buy |
| 2025-02-28 | 開始されました | Piper Sandler | Overweight |
| 2025-02-21 | 開始されました | Wedbush | Outperform |
| 2024-12-19 | 開始されました | BTIG Research | Buy |
| 2024-10-24 | 開始されました | H.C. Wainwright | Neutral |
| 2024-04-16 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-09-24 | 開始されました | RBC Capital Mkts | Outperform |
すべてを表示
Avalo Therapeutics Inc (AVTX) 最新ニュース
Avalo Therapeutics Updates on AVTX-009 and LOTUS Trial - TipRanks
15,323 Shares in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Acquired by Marshall Wace LLP - Defense World
When the Price of (AVTX) Talks, People Listen - news.stocktradersdaily.com
Geode Capital Management LLC Increases Position in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference - The Manila Times
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Up 20.3% in March - Defense World
60,000 Shares in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Purchased by Bank of Montreal Can - Defense World
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $33.00 Average PT from Brokerages - Defense World
Avalo Therapeutics (AVTX) Sees New Options Listings for April | AVTX Stock News - GuruFocus
Seven new option listings and one option delisting on April 16th - TipRanks
Avalo Therapeutics Reports 2024 Financial Results - TipRanks
Advanced Cancer Pain Management Therapeutics Market Size in 7MM - openPR.com
(AVTX) On The My Stocks Page - news.stocktradersdaily.com
AVTX stock touches 52-week low at $5.98 amid market challenges - Investing.com Australia
AVTX stock touches 52-week low at $5.98 amid market challenges By Investing.com - Investing.com South Africa
Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated at Stifel Nicolaus - MarketBeat
Avalo Therapeutics (AVTX) to Release Earnings on Friday - Defense World
Analysts Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $33.00 - Defense World
Avalo Therapeutics names new Chairman amid growth phase By Investing.com - Investing.com South Africa
Avalo Therapeutics Names Michael Heffernan as Board Chairman - MarketScreener
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - GlobeNewswire
Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board - MarketScreener
Avalo Therapeutics names new Chairman amid growth phase - Investing.com
DynaCERT And Avalo Therapeutics Poised For Growth - Evrim Ağacı
Avalo Therapeutics Appoints Michael Heffernan as Chairman - TipRanks
Stifel initiates Avalo Therapeutics stock with a Buy rating By Investing.com - Investing.com Australia
Jefferies Initiates Coverage of Avalo Therapeutics (AVTX) with Buy Recommendation - Nasdaq
Avalo Therapeutics 'Represents An Attractive Pure-Play,' Analyst Initiates Coverage With Over 300% Stock Upside - Benzinga
Jefferies starts Avalo stock with Buy, sets $23 price target By Investing.com - Investing.com Australia
This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Stifel Initiates Coverage of Avalo Therapeutics (AVTX) with Buy Recommendation - Nasdaq
Stifel Initiates Avalo Therapeutics at Buy With $36 Price Target - MarketScreener
How the (AVTX) price action is used to our Advantage - news.stocktradersdaily.com
Jefferies starts Avalo stock with Buy, sets $23 price target - Investing.com
Stifel initiates Avalo Therapeutics stock with a Buy rating - Investing.com India
Oppenheimer maintains Avalo stock Outperform with $35 target By Investing.com - Investing.com Canada
Oppenheimer maintains Avalo stock Outperform with $35 target - Investing.com
Equities Analysts Set Expectations for AVTX Q1 Earnings - Defense World
Wedbush Research Analysts Lift Earnings Estimates for AVTX - Defense World
Wedbush Forecasts Increased Earnings for Avalo Therapeutics - The AM Reporter
HC Wainwright Reiterates Neutral Rating for Avalo Therapeutics (NASDAQ:AVTX) - Defense World
Q1 EPS Estimates for Avalo Therapeutics Boosted by Wedbush - Defense World
Avalo Reports 2024 Financial Results and Recent Business Updates - GlobeNewswire
Avalo Therapeutics Reports Business Updates and Financial Results for 2024, Highlights Phase 2 LOTUS Trial Progress for AVTX-009 in Hidradenitis Suppurativa - Nasdaq
Avalo Therapeutics, Inc. SEC 10-K Report - TradingView
Avalo Therapeutics (AVTX) Expected to Announce Quarterly Earnings on Thursday - Defense World
AVTX’s 52-Week Rollercoaster: From $4.35 to $34.46 – What’s Next for Investors? - The InvestChronicle
PSTV Rallies, TOVX Gears Up For VIRAGE Trial Data, Will AVTX's LOTUS Bloom? - RTTNews
(AVTX) Investment Analysis - Stock Traders Daily
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - Defense World
Avalo Therapeutics (NASDAQ:AVTX) Coverage Initiated at Piper Sandler - Defense World
Avalo Therapeutics Inc (AVTX) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):